CN Patent

CN109414508A — 使用ns5a、ns5b或ns3抑制剂治疗乙型肝炎病毒感染的方法

Assigned to Gilead Sciences Inc · Expires 2019-03-01 · 7y expired

What this patent protects

提供了通过施用NS5A抑制剂、NS5B抑制剂、NS3抑制剂或其组合而治疗乙型肝炎病毒感染的方法。

USPTO Abstract

提供了通过施用NS5A抑制剂、NS5B抑制剂、NS3抑制剂或其组合而治疗乙型肝炎病毒感染的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN109414508A
Jurisdiction: CN
Classification: —
Expires: 2019-03-01
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Sciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.